CL
Colgate-Palmolive Co.
Price performance
Sep 18, 2026About
Company activity
17 events| Time | Ticker | Type | Event | Qty | Price | Value |
|---|---|---|---|---|---|---|
| 07/31 | CL | 8-K | Colgate-Palmolive Announces Quarterly Earnings | — | — | — |
| 05/13 | CL | 8-K | Colgate-Palmolive Elects New Directors and Ratifies Auditor | — | — | — |
| 05/01 | CL | 8-K | Colgate-Palmolive Expands Strategic Growth and Productivity Program | — | — | — |
| 04/09 | CL | 8-K | Colgate-Palmolive Announces Leadership Transition in Legal Department | — | — | — |
| 03/17 | CL | 8-K | Colgate-Palmolive Realigns Reportable Operating Segments | — | — | — |
| 03/12 | CL | 8-K | Colgate-Palmolive Appoints New Board Member and Announces Departure of Existing Director | — | — | — |
| 01/30 | CL | 8-K | Colgate-Palmolive Announces Quarterly Earnings for 2025 | — | — | — |
| 11/10/25 | CL | 8-K | Colgate-Palmolive Announces €600M Senior Notes Issuance | — | — | — |
| 10/31/25 | CL | 8-K | Colgate-Palmolive Announces Q3 Earnings and Initiates Strategic Growth Program | — | — | — |
| 08/01/25 | CL | 8-K | Colgate-Palmolive Reports Second Quarter Earnings and Announces New Productivity Program | — | — | — |
| 05/29/25 | CL | 8-K | Colgate-Palmolive Announces Key Executive Appointments and Promotions | — | — | — |
| 05/14/25 | CL | 8-K | Colgate-Palmolive Stockholders Re-elect Board Members and Approve Key Proposals | — | — | — |
| 05/02/25 | CL | 8-K | Colgate-Palmolive Issues $500 Million in Senior Notes | — | — | — |
| 04/25/25 | CL | 8-K | Colgate-Palmolive Reports Q1 2025 Earnings | — | — | — |
| 01/31/25 | CL | 8-K | Colgate-Palmolive Reports Q4 and Annual 2024 Earnings | — | — | — |
| 01/24/25 | CL | 8-K | Colgate Announces Strong Q3 2024 Results and Business Realignment | — | — | — |
| 10/25/24 | CL | 8-K | Colgate Announces Q3 2024 Earnings and Realigns Skin Health Segment Reporting | — | — | — |
CL filing record
Colgate-Palmolive Co. (CL): 17 8-K filings summarized, the most recent on Jul 31, 2026.
What the 8-K filings said
- Jul 31, 2026 · low impact
Colgate-Palmolive Company announced its earnings for the quarter ended June 30, 2026, as detailed in a press release issued on July 31, 2026. The specific financial results are not detailed in the 8-K filing but are referenced in the attached press release.
Colgate-Palmolive Announces Quarterly Earnings - May 13, 2026 · medium impact
Colgate-Palmolive Company held its Annual Meeting of Stockholders on May 8, 2026, where ten new directors were elected, and the selection of PricewaterhouseCoopers LLP as the independent registered public accounting firm for the year ending December 31, 2026 was ratified. Additionally, a non-binding advisory vote on…
Colgate-Palmolive Elects New Directors and Ratifies Auditor - May 1, 2026 · medium impact
On April 30, 2026, Colgate-Palmolive Company announced an expansion of its Strategic Growth and Productivity Program, which is now estimated to result in cumulative pre-tax charges between $350 million and $550 million. The program, which includes initiatives to optimize the company's global supply chain and…
Colgate-Palmolive Expands Strategic Growth and Productivity Program - Apr 9, 2026 · high impact
Colgate-Palmolive Company announced that Jennifer M. Daniels, its Chief Legal Officer and Secretary since 2014, will retire in 2026. Effective June 1, 2026, Betsy Fishbone, currently Executive Vice President and Deputy Chief Legal Officer, will succeed Daniels as Chief Legal Officer and Secretary. Daniels will…
Colgate-Palmolive Announces Leadership Transition in Legal Department - Mar 17, 2026 · low impact
Colgate-Palmolive Company has realigned its reportable operating segments to optimize and leverage operating scale and drive growth within the Europe, Middle East, and Africa regions. The realignment, effective for the quarter ending March 31, 2026, combines the Europe and Africa/Eurasia segments (excluding Russia and…
Colgate-Palmolive Realigns Reportable Operating Segments
SEC filings in the last five years
- 40 Form 8-K
- 13 Form 10-Q
- 5 Form 10-K
- 1 Form 8-K/A